Original Source(s)
Related Content
Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?
A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.
July 8, 2026
-
3 min
Georgia Eye Partners Welcomes Glaucoma Specialist Dr. Cynthia Guerin
Board-certified ophthalmologist specializing in glaucoma, cataract surgery and comprehensive eye care
August 21, 2026
-
2 min
Standardizing Myopia Control
A new joint position statement urges ophthalmologists and optometrists to standardize contact lens-based myopia control
July 8, 2026
-
4 min